News

美港電訊
2022.09.28 08:22

渤健 (Biogen) 盤前暴漲超 55%，Eisai 和渤健宣佈共同研發的新藥 Lecanemab 在大型試驗中顯示能明顯減緩阿爾茨海默症病情發展。

Source: 美港電訊 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.